5th Annual MarketsandMarkets

Biomarker and Companion Diagnostics Conference

February 6th -7th, 2020

Sheraton San Diego Hotel & Marina, 1380 Harbor Island Dr, CA 92101, United States

Avail Your Ticket Avail
Your Ticket
Become A Sponsor Become
A Sponsor
Become A Speaker Become
A Speaker

30+

Speaker

10+

Networking Hours

4+

Sessions

200+

Attendees

EVENT OVERVIEW

The 5th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 6th - 7th February 2020 in San Diego, CA would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics areas. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

Tag Line
30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research and Future of Companion Diagnostics
Tag Line
Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
Tag Line
Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.

This two-day event will invite 200+ biomarker discovery professionals, 30+ expert speakers and 15+ solution/technology providers to a unique platform to deliver niche buyer-seller ecosystem in the biomarker Industry.

WHAT TO EXPECT

Researchers, Scientists & Clinicians who are active in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development

  • Biomarker Drug Discovery and Assay Development
  • Proteomics and Genomics based Biomarkers
  • Digital Biomarkers, Precision Medicine and Big Data
  • Predictive Biomarkers in targeted Cancer Therapy
  • CDx development and Commercialization
  • Clinical Applications of Biomarkers in Immuno-Oncology
  • Neurology and Inflammatory Diseases

  • Biomarkers In Clinical & Translational Development: Drug Discovery And Assay Development
  • Innovations In Biomarker Research: Digital Biomarkers, Precision Medicine And Big Data
  • From Biomarkers To Cdx: Strategies To Accelerate Cdx Development And Commercialization
  • Clinical Applications Of Biomarkers In Immuno-oncology, Neurology And Inflammatory Diseases

 

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by